8th February 2022

Temporary unavailability of the Astrazeneca COVID-19 Vaccine in St Lucia

By Ministry of Health

The AstraZeneca jab led the way in the UK's vaccine rollout



The Ministry of Health, Wellness & Elderly Affairs informs the public of the temporary unavailability of the Astrazeneca COVID-19 Vaccine.

The last stock in-country expired on January 31, 2022. Due to logistical delays, Saint Lucia has not received its next shipment. Regionally, other countries in the Eastern Caribbean are experiencing the similar situation. The public is assured that the Ministry of Health is making every effort to ensure that the Astrazeneca COVID-19 Vaccine becomes available within the next week.

The Ministry of Health, Wellness & Elderly Affairs also informs the public that the Pfizer BioNTech and Janssen (Johnson & Johnson) vaccines are available at all vaccination sites and Wellness Centres. Both vaccines are safe and can be used as a heterologous combination (mix-and-match) for persons who would have received Astrazeneca as a first dose, or primary series (in the case of persons requiring boosters).

Persons who have not been vaccinated, or are partially vaccinated are encouraged to visit a vaccination site. Vaccination remains the best protection against severe COVID-19 illness, hospitalisation and death. Once again, the Ministry of Health apologizes for any inconvenience this may cause.

For more information please contact the Of ice of the Chief Medical Officer or the Epidemiology Unit, at 468-5309/468-5317 respectively

Advertisement



TO RECEIVE NEWS NOTIFICATIONS And Covid NEWS VIA WHATS APP PLEASE SAVE OUR NUMBER AND SEND US A MESSAGE AT 7584896261 AND WE WILL ADD YOU TO OUR LIST

Trending-News-1
WhatsApp Image 2022-02-07 at 8.13.28 PM
WhatsApp Image 2022-02-06 at 9.03.34 PM
WhatsApp Image 2022-02-05 at 6.33.42 PM (3)
WhatsApp-Image-2022-02-04-at-7.56.48-AM
Screenshot-2022-02-02-4.18.59-PM
sandwich-poster (1)
WhatsApp-Image-2022-01-26-at-6.39.34-PM (1)
WhatsApp Image 2022-02-04 at 3.35.54 PM
WhatsApp-Image-2021-11-11-at-12.19.19-PM-1-1